« Free Wi-Fi at the Bryant Park ice rink |
Main
| Wall Street legend John Gutfreund has been a bad, bad boy »
October 07, 2005
$86 million IPO for Westchester biotech firm
Posted by Dominic Basulto
Acorda Therapeutics, a commercial-stage biopharmaceutical firm that develops products to treat disorders of the central nervous system (i.e. multiple sclerosis and spinal cord injury), has filed with the SEC for an $86 million IPO. The Hawthorne, New York-based company's one marketed product is Zanaflex, which is used to treat involuntary tension, stiffening or contractions of muscles. Acorda also has a promising product in late-stage clinical trials, Fampridine-SR, which is used to help improve walking ability for people who have MS.
Comments (0)
+ TrackBacks (0) | Category: Biotech
POST A COMMENT
- RELATED ENTRIES
- › East Village bar up for sale on eBay
- › Eliot Spitzer takes on the national cinema chains
- › California winemakers to sell wine to New Yorkers via the Internet
- › A blogger could become "Media Person of the Year"
- › A la carte cable TV pricing
- › NYSIA Incubator launch party tonight
- › Why the mathematics of congestion pricing don't work
- › Enjoy the holiday shopping bargains at Century 21 while you can
TrackBack URL:
http://www.corante.com/cgi-bin/mt/external.cgi/31819